Cell & Gene Therapy Clinical Trial Services Market Size Report, 2032

Cell & Gene Therapy Clinical Trial Services Market – By Service (Clinical Trial Design & Planning), Phase, Indication, Therapy Type (Gene, Cell, Gene Modified Cell Therapy), End-use (Pharmaceutical & Biotechnology, CRO) – Global Forecast (2024 ­ 2032)

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market scope &amp; definitions

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3.1&nbsp;&nbsp;&nbsp; Base year calculation

1.3.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.4&nbsp;&nbsp;&nbsp; Forecast model

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.5.2&nbsp;&nbsp;&nbsp; Data mining sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 3600&nbsp;synopsis

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp;Rising incidence of chronic and genetic disease

3.2.1.2&nbsp;&nbsp;&nbsp;Technological advancement in cell and gene therapy

3.2.1.3&nbsp;&nbsp;&nbsp;Increasing investment in research &amp; development activities

3.2.1.4&nbsp;&nbsp;&nbsp;Expanded application in oncology and rare disease

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp;Stringent regulatory challenges

3.2.2.2&nbsp;&nbsp;&nbsp;High development cost

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.6&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2023

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis

4.3&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.4&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.5&nbsp;&nbsp;&nbsp; Strategic dashboard

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Service, 2021-2032 ($ Million)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Clinical trial design &amp; planning

5.3&nbsp;&nbsp;&nbsp; Supply &amp; logistics services

5.4&nbsp;&nbsp;&nbsp; Regulatory affairs &amp; compliance

5.5&nbsp;&nbsp;&nbsp; Data management &amp; biostatistics

5.6&nbsp;&nbsp;&nbsp; Site management &amp; monitoring

5.7&nbsp;&nbsp;&nbsp; Other services

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Phase, 2021-2032 ($ Million)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Phase I

6.3&nbsp;&nbsp;&nbsp; Phase II

6.4&nbsp;&nbsp;&nbsp; Phase III

6.5&nbsp;&nbsp;&nbsp; Phase IV

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Indication, 2021-2032 ($ Million)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Oncology

7.3&nbsp;&nbsp;&nbsp; Hematology

7.4&nbsp;&nbsp;&nbsp; Endocrine/metabolic disorders

7.5&nbsp;&nbsp;&nbsp; Infectious diseases

7.6&nbsp;&nbsp;&nbsp; Neurology

7.7&nbsp;&nbsp;&nbsp; Cardiovascular diseases

7.8&nbsp;&nbsp;&nbsp; Musculoskeletal disorders

7.9&nbsp;&nbsp;&nbsp; Other indications

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Therapy Type, 2021-2032 ($ Million)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; Gene therapy

8.3&nbsp;&nbsp;&nbsp; Cell therapy

8.4&nbsp;&nbsp;&nbsp; Gene modified cell therapy

Chapter 9&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End-Use, 2021-2032 ($ Million)

9.1&nbsp;&nbsp;&nbsp; Key trends

9.2&nbsp;&nbsp;&nbsp; Pharmaceutical &amp; biotechnology companies

9.3&nbsp;&nbsp;&nbsp; Contract research organizations

9.4&nbsp;&nbsp;&nbsp; Academic &amp; research institutes

9.5&nbsp;&nbsp;&nbsp; Other end-users

Chapter 10&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021-2032 ($ Million)

10.1&nbsp;&nbsp;&nbsp; Key trends

10.2&nbsp;&nbsp;&nbsp; North America

10.2.1&nbsp;&nbsp;&nbsp;U.S.

10.2.2&nbsp;&nbsp;&nbsp;Canada

10.3&nbsp;&nbsp;&nbsp; Europe

10.3.1&nbsp;&nbsp;&nbsp;Germany

10.3.2&nbsp;&nbsp;&nbsp;UK

10.3.3&nbsp;&nbsp;&nbsp;France

10.3.4&nbsp;&nbsp;&nbsp;Spain

10.3.5&nbsp;&nbsp;&nbsp;Italy

10.3.6&nbsp;&nbsp;&nbsp;Netherlands

10.3.7&nbsp;&nbsp;&nbsp;Rest of Europe

10.4&nbsp;&nbsp;&nbsp; Asia Pacific

10.4.1&nbsp;&nbsp;&nbsp;Japan

10.4.2&nbsp;&nbsp;&nbsp;China

10.4.3&nbsp;&nbsp;&nbsp;India

10.4.4&nbsp;&nbsp;&nbsp;Australia

10.4.5&nbsp;&nbsp;&nbsp;South Korea

10.4.6&nbsp;&nbsp;&nbsp;Rest of Asia Pacific

10.5&nbsp;&nbsp;&nbsp; Latin America

10.5.1&nbsp;&nbsp;&nbsp;Brazil

10.5.2&nbsp;&nbsp;&nbsp;Mexico

10.5.3&nbsp;&nbsp;&nbsp;Rest of Latin America

10.6&nbsp;&nbsp;&nbsp; Middle East and Africa

10.6.1&nbsp;&nbsp;&nbsp;South Africa

10.6.2&nbsp;&nbsp;&nbsp;Saudi Arabia

10.6.3&nbsp;&nbsp;&nbsp;UAE

10.6.4&nbsp;&nbsp;&nbsp;Rest of Middle East and Africa

Chapter 11&nbsp;&nbsp;&nbsp;Company Profiles

11.1&nbsp;&nbsp;&nbsp; ADVARRA

11.2&nbsp;&nbsp;&nbsp; Charles River Laboratories International Inc.

11.3&nbsp;&nbsp;&nbsp; Catalent Pharma

11.4&nbsp;&nbsp;&nbsp; ICON PLC

11.5&nbsp;&nbsp;&nbsp; IQVIA

11.6&nbsp;&nbsp;&nbsp; Medpace, Inc.

11.7&nbsp;&nbsp;&nbsp; Novotech

11.8&nbsp;&nbsp;&nbsp; Precision Medicine Group, LLC

11.9&nbsp;&nbsp;&nbsp; Parexel International

11.10&nbsp;&nbsp;&nbsp; Syneos Health

11.11&nbsp;&nbsp;&nbsp; Sharp Services, LLC

11.12&nbsp;&nbsp;&nbsp; Thermo Fisher Scientific Inc.

11.13&nbsp;&nbsp;&nbsp; Worldwide Clinical Trials 
&nbsp;

Cell Gene Therapy Clinical Trial Services Market

Get a free sample of this report